HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1852976Generated: October 26, 2026
1,8-Diazabicyclo(5.4.0)undec-7-ene → HCID 53497452, compound
https://huagongshe.com/reaction/1852976
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1,8-Diazabicyclo(5.4.0)undec-7-ene | HCID 81184 | — |
| Reactant | 7-(1-methyl-1H-pyrazol-4-yl)-5-(1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidine | HCID 67452537 | — |
| Reactant | HCID 72739355 | HCID 72739355 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 53497452 | HCID 53497452 | 230.1% |
Reaction Steps
7-(1-Methyl-1H-pyrazol-4-yl)-5-(1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidine (Preparation K; 0.040 mg, 0.15 mmol) was dissolved in dimethylformamide (0.6 mL) and 5,5-dimethylhex-2-enenitrile (Table 1, compound k; 56 mg, 0.045 mmol) and 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine (34 mg, 0.23 mmol) were added and the reaction was heated at 50° C. for 7 hours. The reaction was then cooled and the solvent was removed. The crude reaction was purified by silica gel chromatography using a gradient (1 to 4% MeOH/DCM) to provide 3-(4-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)pentanedinitrile (37 mg, 63% yield) as a solid. MS (apci) m/z=389.2 (M+H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08962596B2 |
|---|
| Source dataset | uspto-grants-2015_02 |
|---|
| ORD ID | ord-b2a679d4f3c8483197ccba5bbd72b913 |
|---|
| Source note | uspto-grants-2015_02 |
|---|